ZMapp is an experimental drug that has shown promise as a treatment for the Ebola virus. We look at the tiny company in San Diego that developed ZMapp, and is now tasked with filling an order from federal officials.
The Ebola Drug
Hey! Did you enjoy this piece? We can’t do it without you. We are member-supported, so your donation is critical to KCRW's music programming, news reporting, and cultural coverage. Help support the DJs, journalists, and staff of the station you love.
Here's how:
- Sign-up for our newsletters.
- Become a KCRW member.
- Subscribe to our Podcasts.
- Donate to KCRW.
- Download our App.
Credits
Guest:
Andrew Pollack - New York Times
Host:
Madeleine Brand
Producers:
Andrew Walsh,
Christian Bordal,
Matt Holzman,
Jolie Myers,
Anna Scott